Inventurus Knowledge Solutions Limited has informed the Exchange about Investor Presentation
IKS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
IKS Health shared its Q1 FY26 investor presentation showing strong financial performance. Revenue grew 16% year-on-year to INR 7,401 million (13% growth in USD terms), driven by 450+ enterprise customers and 95%+ repeat revenue from clients of 5+ years. EBITDA jumped 36% YoY to INR 2,378 million with margins expanding to 32.1% (up from 27.3% a year ago), and profit after tax grew 58.7% YoY to INR 1,515 million with EPS up 57.7% YoY. The company highlighted its AQuity acquisition delivering margin expansion, new client wins including OrthoNY, Mission Community Hospital, and Bicycle Health, and a $17 million investment in WWMG MSO with a 30-year auto-renew contract. They also announced Dr. Garheng Kong (founder of HealthQuest Capital) as a board nominee, strengthening healthcare and capital markets expertise.
Positive for shareholders — strong revenue growth combined with consistent margin expansion and 51% adjusted PAT growth signals healthy business momentum. The new strategic investments and board addition reinforce long-term growth and governance quality, likely to be viewed favorably by the market.